Condition Directory

Parkinson's Disease clinical trials

Directory of U.S. ClinicalTrials.gov public records for Parkinson's Disease. Browse Parkinson's Disease recruiting trials, filter by phase, sponsor, location, or intervention, and open the official ClinicalTrials.gov study record for each result.

By Clinical Trials Finder Guidance last reviewed June 10, 2026 Data synced October 26, 2026 Report an issue

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1412

Shown on this page

Current sort

How Parkinson's Disease studies are organized in the registry

Records generally use the registry spelling “Parkinson disease.” The portfolio mixes drug studies with a high share of device, exercise, and rehabilitation research, so the study-type filter is unusually useful here. Disease-stage language (“early,” “advanced,” “levodopa-treated”) commonly appears in titles.

Terms that often appear in related listings

early Parkinson deep brain stimulation levodopa gait

These describe how studies tend to be titled and grouped on ClinicalTrials.gov — they are search vocabulary, not medical guidance.

Showing 121–132 of 1,412 matching trials for Parkinson's Disease.

Live ClinicalTrials.gov results.

Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.

Live official records

Open in full search

Conditions: Parkinson's Disease
Interventions: ExAblate Transcranial System; Device
Lead sponsor: InSightec; Industry
Eligibility: 30 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Parkinson Disease, Idiopathic
Interventions: Amino acid supplement, Whey Protein Supplement, Isonitrogenous Placebo Supplement; Drug · Dietary Supplement
Lead sponsor: UConn Health; Other
Eligibility: 55 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Parkinson's Disease
Interventions: Nicotinamide Riboside (NR), Oral placebo capsules; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 55 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Parkinson Disease
Interventions: DPA-714-PET/MRI, 5-year Follow-up DPA-714-PET/MRI, DPA-714 Metabolite Analysis; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 30 Years and older
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Young Onset Parkinson Disease, Parkinson Disease
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinsons Disease (PD)
Interventions: NE3107, Placebo; Drug
Lead sponsor: BioVie Inc.; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Farmington Hills, Michigan • Amherst, New York • Morrisville, North Carolina + 1 more

Conditions: Parkinson Disease
Interventions: BIA 28-6156; Drug
Lead sponsor: Bial R&D Investments, S.A.; Industry
Eligibility: Not listed
U.S. locations: 16
States / cities: Phoenix, Arizona • Aurora, Colorado • Boca Raton, Florida + 13 more

Conditions: Freezing of Gait Symptoms in Parkinson's Disease, Deep Brain Stimulation
Interventions: fMRI; Diagnostic Test
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Parkinson's Disease
Interventions: [18F]PI-2620; Drug
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 45 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Parkinson
Interventions: Transcranial Pulse Stimulation (TPS); Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 40 Years to 90 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Parkinson Disease, Depression
Interventions: Psilocybin, Pimavanserin; Drug
Lead sponsor: Joshua Woolley, MD, PhD; Other
Eligibility: 40 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Interventions: Autologous Bone Marrow Aspirate (BMA) and Bone Marrow Aspirate Concentrate (BMAC); Biological
Lead sponsor: Apeiron Research Center; Other
Eligibility: 40 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boulder, Colorado

About this Parkinson's Disease clinical trials directory page

What this page lists: U.S. ClinicalTrials.gov public records that list Parkinson's Disease as a study condition, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
How to narrow results: Use the filters above to scope by intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Parkinson's Disease.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, ranking of trials by quality, or AI-generated medical summaries.

Parkinson's Disease clinical trials

How Parkinson's Disease studies are organized in the registry

Filter and sort this condition

Live official records

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

A Targeted Amino Acid Supplement for People With Parkinson's Disease

NAD Supplementation in Parkinson's Disease

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

A Study of NE3107 in Early Parkinson's

Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study

Imaging Biomarkers of FOG Response to DBS

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Effects of Transcranial Pulse Stimulation in Parkinson's Disease

Psilocybin Therapy for Depression in Parkinson's Disease

Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)

About this Parkinson's Disease clinical trials directory page